| 9461/13381 | US=47 / Câncer Yap TA, Molife LR, Bono JS. CDK inhibitors as anticancer agents. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 135-62. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7. INIBIDORES DE CDK; AGENTES ANTICANCERIGENOS; CICLO CELULAR; CICLINA DEPENDENTE DE QUINASE; CICLINA; INIBIDOR; FLAVOPIRIDOL; UCN-01; E7070; SELICICLIB; BMS 387032; ZD 304709 |
| 9462/13381 | US=47 / Câncer Toyota M, Kashima L, Tokino T. CHFR as a potential anticancer target. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 163-76. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7. CHFR; AGENTE ANTICANCERIGENO; CHECKPOINT MITOTICO; CHECKPOINT PROFASE; TUBULINA; UBIQUITINA LIGASE E3; MITOSE |
| 9463/13381 | US=47 / Câncer Villalona-Calero MA, Schaaf L, Turowski R. Antimicrotubule agents. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 177-205. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7. AGENTES ANTIMICROTUBULOS; TUBULINA; ALCALOIDES DA VINCA; TAXANOS; EPOTILONAS; RESISTENCIA TUMOR; ALBUMINA |
| 9464/13381 | US=47 / Câncer Sarli V, Giannis A. Kinesin motor inhibitors as effective anticancer drugs. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 207-26. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7. INIBIDORES KINESIN; DROGAS ANTICANCER; KINESINAS; ANTIMITOTICOS; EG5 HUMANA |
| 9465/13381 | US=47 / Câncer Kang J, Yu H. Targeting the spindle checkpoint in cancer chemotherapy. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 227-41. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7. SEGMENTACAO DO CHECKPOINT MITOTICO; QUIMIOTERAPIA; MITOSE; SEGREGACAO DOS CROMOSSOMOS; CHECKPOINT MITOTICO; ANEUPLOIDIA; ANAFASE; UBIQUITINACAO; ANTIMITOTICOS; MAD2; CDC20; BUB1 |
| 9466/13381 | US=47 / Câncer Shakalya K, Mahadevan D. Antiproliferation inhibitors targeting aurora kinases. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 243-69. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7. INIBIDORES ANTI-PROLIFERACAO; AURORA QUINASE; MITOSE; CICLO CELULAR; PROTO-ONCOGENES; INIBIDORES DA PROTEINA-QUINASE; ANEUPLOIDIA; CITOCINESE |
| 9467/13381 | US=47 / Câncer Dai W, Yang Y, Jiang N. Plks as novel targets for cancer drug design. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 271-90. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7. PLKS; MEDICAMENTO ANTICANCER; POLO-LIKE QUINASES; PLK1; MITOSE; INIBIDORES; DROGAS ANTI-CANCER; FOSFORILACAO |
| 9468/13381 | US=47 / Câncer Gabrielli B, Stevens F, Beamish H. Do histone deacetylase inhibitors target cell cycle checkpoints that monitor heterochromatin structure?. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 291-309. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7. INIBIDORES DAS HISTONAS DESACETILASES; CONTROLE DO CICLO CELULAR; HETEROCROMATINA; LETALIDADE SINTETICA; PASSAGEIROS CROMOSSOMICOS |
| 9469/13381 | US=44 / Gastro Dellon ES, Shaheen NJ. Epidemiology of gastroesophageal cancer. In: Jankowski J, Sampliner R, Kerr D, Fong Y. Gastrointestinal oncology: a critical multidisciplinary team approach. Massachuetts: Blackwell Scientific Publications, 2008. p. 3-13. ISBN 978-1-4051-2783-7. CANCER GASTROESOFAGICO. EPIDEMIOLOGIA; CANCER DE ESOFAGO. EPIDEMIOLOGIA; ADENOCARCINOMA DE ESOFAGO; CARCINOMA DE CELULAS ESCAMOSAS DO ESOFAGO; ADENOCARCINOMA GASTRICO; NEOPLASIAS GASTRICAS |
| 9470/13381 | US=44 / Gastro Lovell M, Bhan C, Jankowski J, McDonald S. Molecular biology of gastroesophageal cancers: the role of mutational analysis in prognosis. In: Jankowski J, Sampliner R, Kerr D, Fong Y. Gastrointestinal oncology: a critical multidisciplinary team approach. Massachuetts: Blackwell Scientific Publications, 2008. p. 21-30. ISBN 978-1-4051-2783-7. CANCER GASTROESOFAGICO; CANCER GASTRICO. BIOLOGIA MOLECULAR; ANALISE MUTACIONAL NO PROGNOSTICO; CANCER ESOFAGICO. BIOLOGIA MOLECULAR; CARCINOMA DE CELULAS ESCAMOSAS ESOFAGICAS; ADENOCARCINOMA ESOFAGICO |
| 9471/13381 | US=44 / Gastro Barr H. Squamous cancer of the esophagus. In: Jankowski J, Sampliner R, Kerr D, Fong Y. Gastrointestinal oncology: a critical multidisciplinary team approach. Massachuetts: Blackwell Scientific Publications, 2008. p. 114-45. ISBN 978-1-4051-2783-7. CARCINOMA EPIDERMOIDE DE ESOFAGO; CARCINOMA EPIDERMOIDE DE ESOFAGO. DIANGOSTICO; CARCINOMA EPIDERMOIDE DE ESOFAGO. HISTOPATOLOGIA; CARCINOMA EPIDERMOIDE DE ESOFAGO. ESTADIAMENTO; CARCINOMA EPIDERMOIDE DE ESOFAGO. IMAGEM; CARCINOMA EPIDERMOIDE DE ESOFAGO. TRATAMENTO; CARCINOMA EPIDERMOIDE DE ESOFAGO. QUIMIOTERAPIA; CARCINOMA EPIDERMOIDE DE ESOFAGO. RADIOTERAPIA; CARCINOMA EPIDERMOIDE DE ESOFAGO. ABLACAO; CARCINOMA EPIDERMOIDE DE ESOFAGO. AGENTES FARMACOLOGICOS; CARCINOMA EPIDERMOIDE DE ESOFAGO. PROGNOSTICO |
| 9472/13381 | US=44 / Gastro Songun I, van de Velde C. Diffuse gastric cancer. In: Jankowski J, Sampliner R, Kerr D, Fong Y. Gastrointestinal oncology: a critical multidisciplinary team approach. Massachuetts: Blackwell Scientific Publications, 2008. p. 146-76. ISBN 978-1-4051-2783-7. CANCER GASTRICO DIFUSO. DIAGNOSTICO; CANCER GASTRICO DIFUSO. HISTOPATOLOGIA; CANCER GASTRICO DIFUSO. IMAGEM; CANCER GASTRICO DIFUSO. ESTADIAMENTO; CANCER GASTRICO DIFUSO. TRATAMENTO; CANCER GASTRICO DIFUSO. QUIMIOTERAPIA; CANCER GASTRICO DIFUSO. RADIOTERAPIA; CANCER GASTRICO DIFUSO. NOVOS AGENTES; CANCER GASTRICO DIFUSO. PROGNOSTICO |
| 9473/13381 | US=44 / Gastro Wong BCY. Intestinal gastric cancer. In: Jankowski J, Sampliner R, Kerr D, Fong Y. Gastrointestinal oncology: a critical multidisciplinary team approach. Massachuetts: Blackwell Scientific Publications, 2008. p. 177-88. ISBN 978-1-4051-2783-7. CANCER GASTRICO INTESTINAL. DIAGNOSTICO; CANCER GASTRICO INTESTINAL. IMAGEM; CANCER GASTRICO INTESTINAL. ESTADIAMENTO; CANCER GASTRICO INTESTINAL. TRATAMENTO; CANCER GASTRICO INTESTINAL. PROGNOSTICO |
| 9475/13381 | US=44 / Gastro Moayyedi P. Epidemiology and prevention of colorectal cancer. In: Jankowski J, Sampliner R, Kerr D, Fong Y. Gastrointestinal oncology: a critical multidisciplinary team approach. Massachuetts: Blackwell Scientific Publications, 2008. p. 293-304. ISBN 978-1-4051-2783-7. CANCER COLORRETAL. EPIDEMIOLOGIA; CANCER COLORRETAL. PREVENCAO |
| 9476/13381 | US=44 / Gastro Pignatelli M, Banu N, Melegh Z. The molecular pathology of sporadic and hereditary colorectal cancer. In: Jankowski J, Sampliner R, Kerr D, Fong Y. Gastrointestinal oncology: a critical multidisciplinary team approach. Massachuetts: Blackwell Scientific Publications, 2008. p. 305-16. ISBN 978-1-4051-2783-7. CANCER COLORRETAL HEREDITARIO; PATOLOGIA MOLECULAR; POLIPOSE ADENOMATOSA FAMILIAR; CANCER COLORRETAL ESPORADICO; CANCER COLORRETAL HUMANO NAO-POLIPOSE |
| 9477/13381 | US=44 / Gastro Steele RJC. Screening for colorectal cancer. In: Jankowski J, Sampliner R, Kerr D, Fong Y. Gastrointestinal oncology: a critical multidisciplinary team approach. Massachuetts: Blackwell Scientific Publications, 2008. p. 317-24. ISBN 978-1-4051-2783-7. CANCER COLORRETAL. RASTREIO; EXAME DE SANGUE OCULTO NAS FEZES; SIGMOIDOSCOPIA FLEXIVEL; COLONOSCOPIA; RADIOLOGIA |
| 9478/13381 | US=44 / Gastro Midgley RS. Cancer of the colon and rectum. In: Jankowski J, Sampliner R, Kerr D, Fong Y. Gastrointestinal oncology: a critical multidisciplinary team approach. Massachuetts: Blackwell Scientific Publications, 2008. p. 325-73. ISBN 978-1-4051-2783-7. CANCER COLORRETAL. DIAGNOSTICO; CANCER COLORRETAL. HISTOPATOLOGIA; CANCER COLORRETAL. IMAGEM; CANCER COLORRETAL. ESTADIAMENTO; CANCER COLORRETAL. TRATAMENTO; CANCER COLORRETAL. QUIMIOTERAPIA; CANCER COLORRETAL. RADIOTERAPIA; METASTASE HEPATICA. CIRURGIA; ESTOMAS |
| 9479/13381 | US=44 / Gastro McArdle C. Rare cancers. In: Jankowski J, Sampliner R, Kerr D, Fong Y. Gastrointestinal oncology: a critical multidisciplinary team approach. Massachuetts: Blackwell Scientific Publications, 2008. p. 374-407. ISBN 978-1-4051-2783-7. CARCINOIDE GASTROINTESTINAL; MELANOMA ANORRETAL; CANCER DO CANAL ANAL; NEOPLASIAS APENDICULARES; MESOTELIOMA PERITONEAL DIFUSO |
| 9480/13381 | US=44 / Gastro Ghaneh P, Greenhalf W, Neoptolemos JP. Factors involved in carcinogenesis and prevention in hepatobiliary cancer. In: Jankowski J, Sampliner R, Kerr D, Fong Y. Gastrointestinal oncology: a critical multidisciplinary team approach. Massachuetts: Blackwell Scientific Publications, 2008. p. 421-32. ISBN 978-1-4051-2783-7. |